RNA formulation chemistries
Proprietary formulation chemistries with demonstrated track record in mRNA & saRNA formulation, from infectious disease vaccination to personalized cancer vaccine
Quantoom has developed a new class of lipid-like molecules with adaptable heads and interchangeable tails, allowing for customization to achieve specific functionalities.
This versatility enables us to develop a diverse library of lipids-like molecules, each tailored to meet unique therapeutic needs.
Our lipid-like chemistry are free from third-party IP constraints, opening a new possibilities for RNA delivery in an IP-dense market.
DEMONSTRATED SAFETY
Following extended in-vivo evaluation
INCREASED ANTIGEN EXPRESSION
When formulating saRNA, compared to gold-standard formulation
VALIDATED POTENCY
In a murine rabies model, confirming real-world potential
FLEXIBLE LICENSING OPTIONS
Enabling cost-effective synthesis for human health applications
PLATFORM-LIKE CHEMISTRY
The structure of our QCX can be tailored to meet specific requirements
FREE OF ANY THIRD-PARTY IP
Ensuring a clear path to commercialization
For any information request, please contact our team ↓